Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Tri Chemical Laboratories's 3-Year RORE % for the quarter that ended in Apr. 2026 was 32.35%.
The industry rank for Tri Chemical Laboratories's 3-Year RORE % or its related term are showing as below:
FRA:22E's 3-Year RORE % is ranked better than 75.59% of 1520
companies
in the Chemicals industry
Industry Median: 6.445
vs FRA:22E: 32.35
Tri Chemical Laboratories (FRA:22E) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Tri Chemical Laboratories 3-Year RORE % Related Terms
Tri Chemical Laboratories 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:22E vs LIN, SHW, ECL: 3-Year RORE % Comparison
For the Specialty Chemicals subindustry, Tri Chemical Laboratories's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tri Chemical Laboratories 3-Year RORE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tri Chemical Laboratories's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Tri Chemical Laboratories's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Apr. 2026 and 3-year before.
Tri Chemical Laboratories (FRA:22E) has a 3-Year RORE % of 32.35 as of Apr. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Tri Chemical Laboratories and its competitors. According to the industry distribution chart, Tri Chemical Laboratories ranks #371 out of 1520 companies in the Chemicals industry, placing it in the top 24.4%.
Is Tri Chemical Laboratories' 3-Year RORE % too high?
Tri Chemical Laboratories' current 3-Year RORE % is 32.35. The Chemicals industry median 3-Year RORE % is 6.45. Tri Chemical Laboratories' value of 32.35 is 401.9% above this industry median. Based on the distribution chart, Tri Chemical Laboratories ranks #371 out of 1520 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Tri Chemical Laboratories has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tri Chemical Laboratories' 3-Year RORE % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Tri Chemical Laboratories ranks #371 out of 1520 companies for 3-Year RORE %. This places Tri Chemical Laboratories in the top 24% of its industry — outperforming the majority of peers. The industry median 3-Year RORE % is 6.45. Tri Chemical Laboratories' value of 32.35 is 401.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Chemicals company?
The median 3-Year RORE % among Chemicals companies is 6.45, based on 1,520 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tri Chemical Laboratories's current 3-Year RORE % of 32.35 is 401.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Tri Chemical Laboratories and its competitors. For the Chemicals industry, the median 3-Year RORE % is 6.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tri Chemical Laboratories's current 3-Year RORE % is 32.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tri Chemical Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Tri Chemical Laboratories (FRA:22E) is currently considered Significantly Undervalued. The stock's GF Value™ is €26.94, compared to a current price of €18.00 — trading 33.2% below its estimated fair value. The current 3-Year RORE % is 32.35 and 401.9% above the Chemicals industry median of 6.45. Tri Chemical Laboratories' overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Tri Chemical Laboratories (FRA:22E), the current 3-Year RORE % is 32.35 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tri Chemical Laboratories (FRA:22E) Overvalued in 2026?
Based on GuruFocus' analysis, Tri Chemical Laboratories stock appears to be undervalued.
The current stock price of €18.00 is trading 33.2% below its estimated GF Value™ of €26.94.
GuruFocus considers Tri Chemical Laboratories to be Significantly Undervalued.
Key valuation signals for FRA:22E:
3-Year RORE %: 32.35
GF Value™: €26.94 vs. price of €18.00 (33.2% below fair value)
Industry Position: 401.9% above the Chemicals median (#371 of 1520)
No single metric tells the full story. See the FRA:22E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:22E has been successfully added to your 
